Todd Shegog is SVP, Chief Financial Officer of Forma Therapeutics Holdings, Inc.. Currently has a direct ownership of 0 shares of FMTX, which is worth approximately $0. The most recent transaction as insider was on Oct 14, 2022, when has been sold 56,143 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Todd Shegog Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 14 2022
SELL
Disposition due to a tender of shares in a change of control transaction
-
56,143 Reduced 100.0%
0 Common Stock
Feb 28 2022
BUY
Grant, award, or other acquisition
-
33,330 Added 37.25%
56,143 Common Stock
Feb 23 2022
SELL
Open market or private sale
$55,619 $9.78 p/Share
5,687 Reduced 19.95%
22,813 Common Stock
Feb 26 2021
BUY
Grant, award, or other acquisition
-
28,500 Added 50.0%
28,500 Common Stock

Also insider at

COGT
Cogent Biosciences, Inc. Healthcare
TS

Todd Shegog

SVP, Chief Financial Officer
Cambridge, MA

Track Institutional and Insider Activities on FMTX

Follow Forma Therapeutics Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FMTX shares.

Notify only if

Insider Trading

Get notified when an Forma Therapeutics Holdings, Inc. insider buys or sells FMTX shares.

Notify only if

News

Receive news related to Forma Therapeutics Holdings, Inc.

Track Activities on FMTX